PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
Start Date
7/28/2025
Completion Date
12/28/2028
Summary
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of their regular medical care for maintaining long-term dialysis access when all other dialysis access options have failed. If participants in the study are not seen for a standard of care clinic visit during the 4 visit timepoints over 2 years, the participant will be followed by phone to check their current health and dialysis status.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
HeRO® Graft System or Super HeRO® System
Conditions
Locations
MedStar Washington Hospital Center
Washington D.C., District of Columbia 20010
United States
Sarasota Memorial Health Care System
Sarasota, Florida 34239
United States
WakeMed
Raleigh, North Carolina 27610
United States
University Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15219
United States
Baylor Scott & White Heart and Vascular Hospital - Dallas
Dallas, Texas 75226
United States
Houston Methodist Hospital
Houston, Texas 77030
United States
Sentara Norfolk General Hospital
Norfolk, Virginia 23507
United States